Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

The stock's fall snapped a two-day winning streak.

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

PTC Industries inks aerospace MoU with Odisha government, sparking a nearly 5% rally in the company’s stock price.

One of the top advanced manufacturing and material technology companies, PTC Industries, has inked a Memorandum of ...

Check the time stamp on this data. Updated AI-Generated Signals for Ptc Inc. (PTC) available here: PTC. Type a few symbols ...

PTC automatically controls train speeds when needed, reducing the risk of train collisions and preventing human error, while ...